Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00306930
Other study ID # PIN
Secondary ID
Status Completed
Phase N/A
First received March 23, 2006
Last updated July 28, 2014
Start date July 2000
Est. completion date December 2012

Study information

Verified date July 2014
Source DePuy Orthopaedics
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

This study is a clinical evaluation of survivorship of an acetabular cup system after total hip replacement using patient examinations and questionnaires.


Description:

The primary objective of this investigation is to evaluate survivorship at five years of the Pinnacleâ„¢ acetabular cup system in primary total hip arthroplasty.


Recruitment information / eligibility

Status Completed
Enrollment 1593
Est. completion date December 2012
Est. primary completion date December 2012
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- Primary hip replacement

- Sufficient bone stock to support implant

- Signed Informed Patient Consent form

Exclusion Criteria:

- Prior renal transplant

- History of active joint sepsis

- Recent high dose of corticosteroids

- Primary or secondary carcinoma in the last 5 years

- Neurological disease

- Psychosocial disease that would limit rehabilitation

- Use of structural bone graft

- Simultaneous participation in another hip study

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Intervention

Device:
Acetabular cup
Acetabular cup replacement

Locations

Country Name City State
United States DePuy Orthopaedics Warsaw Indiana

Sponsors (1)

Lead Sponsor Collaborator
DePuy Orthopaedics

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Survivorship 5 years Yes
Secondary Harris Hip Score Pre-operative, 6 month and 1, 2, 3, 4, and 5 years. No
Secondary Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pre-operative, 6 month and 1, 2, 3, 4 and 5 years. No
Secondary Short Form-36 (SF-36) Pre-operative, 6 month and 1, 2, 3, 4 and 5 years. No
See also
  Status Clinical Trial Phase
Completed NCT04226131 - MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics N/A
Completed NCT04171414 - A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis Phase 3
Completed NCT02833350 - Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA) Phase 2
Completed NCT04255134 - Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN) Phase 4
Recruiting NCT05615246 - Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
Completed NCT03248518 - Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases N/A
Completed NCT03514355 - MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms N/A
Recruiting NCT06005220 - SBD121, a Synbiotic Medical Food for RA Management N/A
Recruiting NCT05451615 - Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis Phase 3
Completed NCT05054920 - Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis N/A
Completed NCT02037737 - Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting N/A
Recruiting NCT04079374 - Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel Phase 3
Completed NCT02504268 - Effects of Abatacept in Patients With Early Rheumatoid Arthritis Phase 3
Recruiting NCT05496855 - Remote Care in People With Rheumatoid Arthritis N/A
Completed NCT05051943 - A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
Recruiting NCT06031415 - Study of GS-0272 in Participants With Rheumatoid Arthritis Phase 1
Recruiting NCT06103773 - A Study of Single and Multiple Oral Doses of TollB-001 Phase 1
Completed NCT05999266 - The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
Recruiting NCT05302934 - Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
Recruiting NCT04169100 - Novel Form of Acquired Long QT Syndrome Phase 4